Article
COVID-19 – the Next Wave of Vaccines and Therapeutics
IQVIA Pipeline Intelligence
Apr 11, 2022
Download

Two years into the COVID-19 pandemic, the emergence of potent variants has highlighted the need for newer and different vaccines that improve benefit. Researchers have made advances with the development of recombinant VLP vaccines which have repetitive surface patterns enabling the triggering of strong immune responses, plant-based vaccines that can be rapidly produced and stored for a longer period of time and self-amplifying RNA vaccines that have enhanced antigen expression at lower doses compared with conventional mRNA. However, further innovations

are urgently required to develop more effective vaccines and ultimately a pan-coronavirus vaccine that can protect against all SARS-CoV-2 variants and multiple types of coronaviruses. In conjunction with vaccines, the development of therapies could also form an additional strategy to combat COVID-19 and treat individuals who are infected.

This article will outline the latest key selected developments for COVID-19 treatments with data sourced from IQVIA Pipeline Intelligence proprietary drug pipeline database.

Contact Us